Glucose and fatty acid metabolism in infarcted heart from streptozotocin-induced diabetic rats after 2weeks of tissue remodeling

Cardiovascular Diabetology

Volumn 14, Issue 1, 2015, Pages

  Malfitano, Christiane ^a   de Souza Junior, Alcione Lescano ^a,b   Carbonaro, Mariana ^a   Bolsoni Lopes, Andressa ^a   Figueroa, Diego ^a   de Souza, Leandro Ezequiel ^a   Silva, Kleiton Augusto Santos ^c   Consolim Colombo, Fernanda ^a,d   Curi, Rui ^a   Irigoyen, Maria Claudia ^a,d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE DO ESTADO DE MATO GROSSO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSIDADE NOVE DE JULHO   (Brazil)

Author keywords

Diabetic hyperglycemia; Fatty acid metabolism; Glucose metabolism; Myocardial infarction; Remodeling

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ADENOSINE TRIPHOSPHATE; CARNITINE PALMITOYLTRANSFERASE I; CITRATE SYNTHASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCOGEN; HEXOKINASE; TRIACYLGLYCEROL; CARNITINE PALMITOYLTRANSFERASE; FATTY ACID; GLUCOSE BLOOD LEVEL; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRIFUGATION; CITRIC ACID CYCLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME ANALYSIS; FATTY ACID METABOLISM; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLYCOGEN ANALYSIS; GLYCOGENOLYSIS; GLYCOLYSIS; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE METABOLISM; HEART VENTRICLE REMODELING; ISCHEMIC PRECONDITIONING; MALE; MEDICAL SOCIETY; NONHUMAN; PROTEIN CONTENT; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; BLOOD; CARDIAC MUSCLE; COMPLICATION; ENERGY METABOLISM; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SYSTOLE; TIME FACTOR; WISTAR RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD GLUCOSE; CARNITINE O-PALMITOYLTRANSFERASE; CITRIC ACID CYCLE; DIABETES MELLITUS, EXPERIMENTAL; ENERGY METABOLISM; FATTY ACIDS; GLYCOGEN; GLYCOLYSIS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS, WISTAR; REACTIVE OXYGEN SPECIES; STROKE VOLUME; SYSTOLE; TIME FACTORS; TRIGLYCERIDES; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84946741956     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-015-0308-y     Document Type: Article

References (50)

1. Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM. Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ. 2001;322:1389-93. doi: 10.1136/bmj.322.7299.1389.
2. Ravingerova T, Neckar J, Kolar F. Ischemic tolerance of rat hearts in acute and chronic phases of experimental diabetes. Mol Cell Biochem. 2003;249:167-74.
3. Feuvray D, Lopaschuk GD. Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc Res. 1997;34:113-20. doi: 10.1016/S0008-6363(97)00037-0.
4. Ravingerova T, Neckar J, Kolar F, Stetka R, Volkovova K, Ziegelhöffer A, et al. Ventricular arrhythmias following coronary artery occlusion in rats: is the diabetic heart less or more sensitive to ischaemia? Basic Res Cardiol. 2001;96:160-8. doi: 10.1007/s003950170066.
5. Bäcklund T, Palojoki E, Saraste A, Eriksson A, Finckenberg P, Kytö V, et al. Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes. Diabetologia. 2004;47:325-30. doi: 10.1007/s00125-003-1311-5.
6. Shishido T, Woo CH, Ding B, McClain C, Molina CA, Yan C, et al. Effects of MEK5/ERK5 association on small ubiquitin-related modification of ERK5: implications for diabetic ventricular dysfunction after myocardial infarction. Circ Res. 2008;102(11):1416-25. doi: 10.1161/CIRCRESAHA.107.168138.
7. Malfitano C, lba Loureiro TC, Rodrigues B, Sirvente R, Salemi VM, Rabechi NB, et al. Hyperglycaemia protects the heart after myocardial infarction: aspects of programmed cell survival and cell death. Eur J Heart Fail. 2010;12:659-67. doi: 10.1093/eurjhf/hfq053.
8. Malfitano C, Barboza CA, Mostarda C, da Palma RK, dos Santos CP, Rodrigues B, et al. Diabetic hyperglycemia attenuates sympathetic dysfunction and oxidative stress after myocardial infarction in rats. Cardiovasc Diabetol. 2014;13:131. doi: 10.1186/s12933-014-0131-x.
9. Ho YJ, Lee AS, Chen WP, Chang WL, Tsai YK, Chiu HL, et al. Caffeic acid phenethyl amide ameliorates ischemia/reperfusion injury and cardiac dysfunction in streptozotocin-induced diabetic rats. Cardiovasc Diabetol. 2014;13:98. doi: 10.1186/1475-2840-13-98.
10. Li H, Liu Z, Wang J, Wong GT, Cheung CW, Zhang L, et al. Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats. Cardiovasc Diabetol. 2013;12:133. doi: 10.1186/1475-2840-12-133.
11. Harmancey R, Vasquez HG, Guthrie PH, Taegtmeyer H. Decreased long-chain fatty acid oxidation impairs postischemic recovery of the insulin-resistant rat heart. FASEB J. 2013;27(10):3966-78. doi: 10.1096/fj.13-234914.
12. Ravingerova T, Stetka R, Volkovova K, Pancza D, Dzurba A, Ziegelhöffer A, et al. Acute diabetes modulates response to ischemia in isolated rat heart. Mol Cell Biochem. 2000;210(1-2):143-51.
13. Chu LM, Osipov RM, Robich MP, Feng J, Oyamada S, Bianchi C, et al. Is hyperglycemia bad for the heart during acute ischemia? J Thorac Cardiovasc Surg. 2010;140(6):1345-52. doi: 10.1016/j.jtcvs.2010.05.009.
14. Rochetaing A, Kreher P. Reactive hyperemia during early reperfusion as a determinant of improved functional recovery in ischemic preconditioned rat hearts. J Thorac Cardiovasc Surg. 2003;125(6):1516-25.
15. Eguchi M, Kim YH, Kang KW, Shim CY, Jang Y, Dorval T, et al. Ischemia-reperfusion injury leads to distinct temporal cardiac remodeling in normal versus diabetic mice. PLoS One. 2012;7(2):e30450. doi: 10.1371/journal.pone.0030450.
16. Gamble J, Lopaschuk GD. Glycolysis and glucose oxidation during reperfusion of ischemic hearts from diabetic rats. Biochim Biophys Acta. 1994;1225(2):191-9.
17. Mapanga RF, Rajamani U, Dlamini N, Zungu-Edmondson M, Kelly-Laubscher R, Shafiullah M, et al. Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction. PLoS One. 2012;7(10):e47322. doi: 10.1371/journal.pone.0047322.
18. Rodrigues B, Figueroa DM, Fang J, Rosa KT, Llesuy S, De Angelis K, et al. Short-term diabetes attenuates left ventricular dysfunction and mortality rates after myocardial infarction in rodents. Clinics (Sao Paulo). 2011;66(8):1437-42. doi: 10.1590/S1807-59322011000800022.
19. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8(6):e1000412. doi: 10.1371/journal.pbio.1000412.
20. Yuan Q, Zhan L, Zhou QY, Zhang LL, Chen XM, Hu XM, et al. SIRT2 regulates microtubule stabilization in diabetic cardiomyopathy. Eur J Pharmacol. 2015;764:554-61. doi: 10.1016/j.ejphar.2015.07.045.
21. Akhtar MS, Pillai KK, Hassan Q, Ansari SH, Ali J, Akhtar M, et al. Levosimendan suppresses oxidative injury, apoptotic signaling and mitochondrial degeneration in streptozotocin-induced diabetic cardiomyopathy. Clin Exp Hypertens. 2015;24:1-13.
22. Rodrigues B, Rosa KT, Medeiros A, Schaan BD, Brum PC, De Angelis K, et al. Hyperglycemia can delay left ventricular dysfunction but not autonomic damage after myocardial infarction in rodents. Cardiovasc Diabetol. 2011;10:26. doi: 10.1186/1475-2840-10-52.
23. Wichi R, Malfitano C, Rosa K, De Souza SB, Salemi V, Mostarda C, et al. Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents. Cardiovasc Diabetol. 2007;6:14. doi: 10.1186/1475-2840-6-14.
24. Braga LM, Rosa K, Rodrigues B, Malfitano C, Camassola M, Chagastelles P, et al. Systemic delivery of adult stem cells improves cardiac function in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 2008;35:113-9. doi: 10.1111/j.1440-1681.2007.04820.x.
25. dos Santos L, Mello AF, Antonio EL, Tucci PJ. Determination of myocardial infarction size in rats by echocardiography and tetrazolium staining: correlation, agreements, and simplifications. Braz J Med Biol Res. 2008;41:199-201. doi: 10.1590/S0100-879X2008005000007.
26. Decker K, Keppler D. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol. 1974;71:77-106.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
28. Crabtree B, Newsholme EA. The activities of phosphorylase, hexokinase, phosphofructokinase, lactate dehydrogenase and the glycerol 3-phosphate dehydrogenases in muscles from vertebrates and invertebrates. Biochem J. 1972;126(1):49-58.
29. Srere PA. Citrate synthase. Methods Enzymol. 1969;13:3-5.
30. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-5.
31. Laybutt DR, Thompson AL, Cooney GJ, Kraegen EW. Selective chronic regulation of GLUT1 and GLUT4 content by insulin, glucose, and lipid in rat cardiac muscle in vivo. Am J Physiol. 1997;273:H1309-16.
32. Ji XB, Li XR, Hao-Ding Sun Q, Zhou Y, Wen P, et al. Inhibition of uncoupling protein 2 attenuates cardiac hypertrophy induced by transverse aortic constriction in mice. Cell Physiol Biochem. 2015;36:1688-98. doi: 10.1159/000430142.
33. Naserzadeh P, Hosseini MJ, MohamadzadehAsl B, Pourahmad J. Toxicity mechanisms of cigarette smoke on mouse fetus mitochondria. Iran J Pharm Res. 2015;14(Suppl):131-8.
34. Isfort M, Stevens SC, Schaffer S, Jong CJ, Wold LE. Metabolic dysfunction in diabetic cardiomyopathy. Heart Fail Rev. 2014;19(1):35-48. doi: 10.1007/s10741-013-9377-8.
35. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785-9.
36. Barsotti A, Giannoni A, Di Napoli P, Emdin M. Energy metabolism in the normal and in the diabetic heart. Curr Pharm Des. 2009;15(8):836-40. doi: 10.2174/138161209787582066.
37. Hirabara SM, Curi R, Maechler P. Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells. J Cell Physiol. 2010;222(1):187-94. doi: 10.1002/jcp.21936.
38. Pinheiro CH, Silveira LR, Nachbar RT, Vitzel KF, Curi R. Regulation of glycolysis and expression of glucose metabolism-related genes by reactive oxygen species in contracting skeletal muscle cells. Free Radic Biol Med. 2010;48(7):953-60. doi: 10.1016/j.freeradbiomed.2010.01.016.
39. Kokubun E, Hirabara SM, Fiamoncini J, Curi R, Haebisch H. Changes of glycogen content in liver, skeletal muscle, and heart from fasted rats. Cell Biochem Funct. 2009;27(7):488-95. doi: 10.1002/cbf.1602.
40. Malfitano C, de Souza Junior AL, Irigoyen MC. Impact of conditioning hyperglycemic on myocardial infarction rats: Cardiac cell survival factors. World J Cardiol. 2014;6(6):449-54. doi: 10.4330/wjc.v6.i6.449.
41. Egorova MV, Afanas'ev SA, Popov SV, Karpov RS. Manifestation of adaptive changes during combined development of postinfarction remodeling of the heart and diabetes mellitus. Bull Exp Biol Med. 2010;150(2):172-4.
42. Masoud WG, Ussher JR, Wang W, Jaswal JS, Wagg CS, Dyck JR, et al. Failing mouse hearts utilize energy inefficiently and benefit from improved coupling of glycolysis and glucose oxidation. Cardiovasc Res. 2014;101(1):30-8. doi: 10.1093/cvr/cvt216.
43. Akhmedov AT, Rybin V, Marín-García J. Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart. Heart Fail Rev. 2015;20(2):227-49. doi: 10.1007/s10741-014-9457-4.
44. Duerr GD, Heinemann JC, Arnoldi V, Feisst A, Kley J, Ghanem A, et al. Cardiomyocyte specific peroxisome proliferator-activated receptor-aα overexpression leads to irreversible damage in ischemic murine heart. Life Sci. 2014;102(2):88-97. doi: 10.1016/j.lfs.2014.03.019.
45. Hughey CC, Ma L, James FD, Bracy DP, Wang Z, Wasserman DH, et al. Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart. Cardiovasc Diabetol. 2013;12:128. doi: 10.1186/1475-2840-12-128.
46. Hausenloy DJ, Whittington HJ, Wynne AM, Begum SS, Theodorou L, Riksen N, et al. Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner. Cardiovasc Diabetol. 2013;12:154. doi: 10.1186/1475-2840-12-154.
47. Lung TW, Petrie D, Herman WH, Palmer AJ, Svensson AM, Eliasson B, et al. Severe hypoglycemia and mortality after cardiovascular events for type 1 diabetic patients in Sweden. Diabetes Care. 2014;37(11):2974-81. doi: 10.2337/dc14-0405.
48. Rana OA, Byrne CD, Greaves K. Intensive glucose control and hypoglycaemia: a new cardiovascular risk factor? Heart. 2014;100(1):21-7. doi: 10.1136/heartjnl-2013-303871.
49. Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal TP, Wetterslev J. WITHDRAWN: targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2015;7:CD008143.
50. Liepinsh E, Makrecka M, Kuka J, Makarova E, Vilskersts R, Cirule H, et al. The heart is better protected against myocardial infarction in the fed state compared to the fasted state. Metabolism. 2014;63(1):127-36. doi: 10.1016/j.metabol.2013.09.014.